189 related articles for article (PubMed ID: 18824600)
1. A key role for G-CSF-induced neutrophil production and trafficking during inflammatory arthritis.
Eyles JL; Hickey MJ; Norman MU; Croker BA; Roberts AW; Drake SF; James WG; Metcalf D; Campbell IK; Wicks IP
Blood; 2008 Dec; 112(13):5193-201. PubMed ID: 18824600
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Targeting of the G-CSF Receptor Reduces Neutrophil Trafficking and Joint Inflammation in Antibody-Mediated Inflammatory Arthritis.
Campbell IK; Leong D; Edwards KM; Rayzman V; Ng M; Goldberg GL; Wilson NJ; Scalzo-Inguanti K; Mackenzie-Kludas C; Lawlor KE; Wicks IP; Brown LE; Baz Morelli A; Panousis C; Wilson MJ; Nash AD; McKenzie BS; Andrews AE
J Immunol; 2016 Dec; 197(11):4392-4402. PubMed ID: 27807194
[TBL] [Abstract][Full Text] [Related]
3. Overproduced bone marrow neutrophils in collagen-induced arthritis are primed for NETosis: An ignored pathological cell involving inflammatory arthritis.
Xu D; Lin Y; Shen J; Zhang J; Wang J; Zhang Y; Zhang H; Ning L; Liu P; Li S; Zeng H; Lin J; Yu C
Cell Prolif; 2020 Jul; 53(7):e12824. PubMed ID: 32567730
[TBL] [Abstract][Full Text] [Related]
4. GRK6 deficiency is associated with enhanced CXCR4-mediated neutrophil chemotaxis in vitro and impaired responsiveness to G-CSF in vivo.
Vroon A; Heijnen CJ; Raatgever R; Touw IP; Ploemacher RE; Premont RT; Kavelaars A
J Leukoc Biol; 2004 Apr; 75(4):698-704. PubMed ID: 14704365
[TBL] [Abstract][Full Text] [Related]
5. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
6. Regulation of systemic and local myeloid cell subpopulations by bone marrow cell-derived granulocyte-macrophage colony-stimulating factor in experimental inflammatory arthritis.
Cook AD; Turner AL; Braine EL; Pobjoy J; Lenzo JC; Hamilton JA
Arthritis Rheum; 2011 Aug; 63(8):2340-51. PubMed ID: 21809323
[TBL] [Abstract][Full Text] [Related]
7. Bone- and cartilage-protective effects of a monoclonal antibody against colony-stimulating factor 1 receptor in experimental arthritis.
Toh ML; Bonnefoy JY; Accart N; Cochin S; Pohle S; Haegel H; De Meyer M; Zemmour C; Preville X; Guillen C; Thioudellet C; Ancian P; Lux A; Sehnert B; Nimmerjahn F; Voll RE; Schett G
Arthritis Rheumatol; 2014 Nov; 66(11):2989-3000. PubMed ID: 24623505
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo effects of granulocyte colony-stimulating factor on neutrophils in glycogen storage disease type 1B: granulocyte colony-stimulating factor therapy corrects the neutropenia and the defects in respiratory burst activity and Ca2+ mobilization.
McCawley LJ; Korchak HM; Douglas SD; Campbell DE; Thornton PS; Stanley CA; Baker L; Kilpatrick L
Pediatr Res; 1994 Jan; 35(1):84-90. PubMed ID: 7510873
[TBL] [Abstract][Full Text] [Related]
9. Macrophage migration inhibitory factor regulates neutrophil chemotactic responses in inflammatory arthritis in mice.
Santos LL; Fan H; Hall P; Ngo D; Mackay CR; Fingerle-Rowson G; Bucala R; Hickey MJ; Morand EF
Arthritis Rheum; 2011 Apr; 63(4):960-70. PubMed ID: 21452319
[TBL] [Abstract][Full Text] [Related]
10. Complementary action of granulocyte macrophage colony-stimulating factor and interleukin-17A induces interleukin-23, receptor activator of nuclear factor-κB ligand, and matrix metalloproteinases and drives bone and cartilage pathology in experimental arthritis: rationale for combination therapy in rheumatoid arthritis.
van Nieuwenhuijze AE; van de Loo FA; Walgreen B; Bennink M; Helsen M; van den Bersselaar L; Wicks IP; van den Berg WB; Koenders MI
Arthritis Res Ther; 2015 Jun; 17(1):163. PubMed ID: 26081345
[TBL] [Abstract][Full Text] [Related]
11. Granulocyte colony-stimulating factor (G-CSF) plays an important role in immune complex-mediated arthritis.
Christensen AD; Haase C; Cook AD; Hamilton JA
Eur J Immunol; 2016 May; 46(5):1235-45. PubMed ID: 26848119
[TBL] [Abstract][Full Text] [Related]
12. Critical role for granulocyte colony-stimulating factor in inflammatory arthritis.
Lawlor KE; Campbell IK; Metcalf D; O'Donnell K; van Nieuwenhuijze A; Roberts AW; Wicks IP
Proc Natl Acad Sci U S A; 2004 Aug; 101(31):11398-403. PubMed ID: 15272075
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of role of G-CSF in the production, survival, and release of neutrophils from bone marrow into circulation.
Basu S; Hodgson G; Katz M; Dunn AR
Blood; 2002 Aug; 100(3):854-61. PubMed ID: 12130495
[TBL] [Abstract][Full Text] [Related]
14. IFNγ inhibits G-CSF induced neutrophil expansion and invasion of the CNS to prevent viral encephalitis.
Ramakrishna C; Cantin EM
PLoS Pathog; 2018 Jan; 14(1):e1006822. PubMed ID: 29352287
[TBL] [Abstract][Full Text] [Related]
15. G-CSF Receptor Blockade Ameliorates Arthritic Pain and Disease.
Lee MC; McCubbin JA; Christensen AD; Poole DP; Rajasekhar P; Lieu T; Bunnett NW; Garcia-Caraballo S; Erickson A; Brierley SM; Saleh R; Achuthan A; Fleetwood AJ; Anderson RL; Hamilton JA; Cook AD
J Immunol; 2017 May; 198(9):3565-3575. PubMed ID: 28320832
[TBL] [Abstract][Full Text] [Related]
16. Protection from collagen-induced arthritis in granulocyte-macrophage colony-stimulating factor-deficient mice.
Campbell IK; Rich MJ; Bischof RJ; Dunn AR; Grail D; Hamilton JA
J Immunol; 1998 Oct; 161(7):3639-44. PubMed ID: 9759887
[TBL] [Abstract][Full Text] [Related]
17. Granulocyte colony-stimulating factor (G-CSF) increases neutrophil migration across vascular endothelium independent of an effect on adhesion: comparison with granulocyte-macrophage colony-stimulating factor (GM-CSF).
Yong KL
Br J Haematol; 1996 Jul; 94(1):40-7. PubMed ID: 8757506
[TBL] [Abstract][Full Text] [Related]
18. The colony-stimulating factors and collagen-induced arthritis: exacerbation of disease by M-CSF and G-CSF and requirement for endogenous M-CSF.
Campbell IK; Rich MJ; Bischof RJ; Hamilton JA
J Leukoc Biol; 2000 Jul; 68(1):144-50. PubMed ID: 10914502
[TBL] [Abstract][Full Text] [Related]
19. Torilin ameliorates type II collagen-induced arthritis in mouse model of rheumatoid arthritis.
Endale M; Lee WM; Kwak YS; Kim NM; Kim BK; Kim SH; Cho J; Kim S; Park SC; Yun BS; Ko D; Rhee M
Int Immunopharmacol; 2013 Jun; 16(2):232-42. PubMed ID: 23623942
[TBL] [Abstract][Full Text] [Related]
20. Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease.
Cook AD; Braine EL; Campbell IK; Rich MJ; Hamilton JA
Arthritis Res; 2001; 3(5):293-8. PubMed ID: 11549370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
